Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 360

1.

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk.

Walsh CS, Miller CW, Karlan BY, Koeffler HP.

Gynecol Oncol. 2007 Mar;104(3):660-4. Epub 2006 Nov 21.

PMID:
17123590
[PubMed - indexed for MEDLINE]
2.

MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.

Ohmiya N, Taguchi A, Mabuchi N, Itoh A, Hirooka Y, Niwa Y, Goto H.

J Clin Oncol. 2006 Sep 20;24(27):4434-40.

PMID:
16983111
[PubMed - indexed for MEDLINE]
Free Article
3.

Association of breast cancer outcome with status of p53 and MDM2 SNP309.

Boersma BJ, Howe TM, Goodman JE, Yfantis HG, Lee DH, Chanock SJ, Ambs S.

J Natl Cancer Inst. 2006 Jul 5;98(13):911-9.

PMID:
16818855
[PubMed - indexed for MEDLINE]
Free Article
4.

MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population.

Lum SS, Chua HW, Li H, Li WF, Rao N, Wei J, Shao Z, Sabapathy K.

Carcinogenesis. 2008 Apr;29(4):754-61. doi: 10.1093/carcin/bgn024. Epub 2008 Feb 14.

PMID:
18281248
[PubMed - indexed for MEDLINE]
Free Article
5.

Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancer.

Lind H, Zienolddiny S, Ekstrøm PO, Skaug V, Haugen A.

Int J Cancer. 2006 Aug 1;119(3):718-21.

PMID:
16496380
[PubMed - indexed for MEDLINE]
6.

The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck.

Alhopuro P, Ylisaukko-Oja SK, Koskinen WJ, Bono P, Arola J, Järvinen HJ, Mecklin JP, Atula T, Kontio R, Mäkitie AA, Suominen S, Leivo I, Vahteristo P, Aaltonen LM, Aaltonen LA.

J Med Genet. 2005 Sep;42(9):694-8.

PMID:
16141004
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Interaction of Helicobacter pylori with genetic variants in the MDM2 promoter, is associated with gastric cancer susceptibility in Chinese patients.

Wang X, Yang J, Ho B, Yang Y, Huang Z, Zhang Z, Zhang G.

Helicobacter. 2009 Oct;14(5):114-9. doi: 10.1111/j.1523-5378.2009.00712.x.

PMID:
19751436
[PubMed - indexed for MEDLINE]
8.

MDM2 SNP309T>G polymorphism and risk of hepatocellular carcinoma: a case-control analysis in a Moroccan population.

Ezzikouri S, El Feydi AE, Afifi R, El Kihal L, Benazzouz M, Hassar M, Marchio A, Pineau P, Benjelloun S.

Cancer Detect Prev. 2009;32(5-6):380-5. doi: 10.1016/j.cdp.2009.01.003. Epub 2009 Feb 23.

PMID:
19233569
[PubMed - indexed for MEDLINE]
9.

Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.

Menin C, Scaini MC, De Salvo GL, Biscuola M, Quaggio M, Esposito G, Belluco C, Montagna M, Agata S, D'Andrea E, Nitti D, Amadori A, Bertorelle R.

J Natl Cancer Inst. 2006 Feb 15;98(4):285-8.

PMID:
16478747
[PubMed - indexed for MEDLINE]
Free Article
10.

MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.

Dong HJ, Fang C, Fan L, Zhu DX, Wang DM, Zhu HY, Zhuang Y, Miao KR, Liu P, Xu W, Li JY.

Int J Cancer. 2012 May 1;130(9):2054-61. doi: 10.1002/ijc.26222. Epub 2011 Aug 9.

PMID:
21647873
[PubMed - indexed for MEDLINE]
11.

Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers.

Copson ER, White HE, Blaydes JP, Robinson DO, Johnson PW, Eccles DM.

BMC Cancer. 2006 Mar 24;6:80.

PMID:
16563154
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.

Hirata H, Hinoda Y, Kikuno N, Kawamoto K, Suehiro Y, Tanaka Y, Dahiya R.

Clin Cancer Res. 2007 Jul 15;13(14):4123-9.

PMID:
17634539
[PubMed - indexed for MEDLINE]
Free Article
13.

Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients.

Cattelani S, Defferrari R, Marsilio S, Bussolari R, Candini O, Corradini F, Ferrari-Amorotti G, Guerzoni C, Pecorari L, Menin C, Bertorelle R, Altavista P, McDowell HP, Boldrini R, Dominici C, Tonini GP, Raschellà G, Calabretta B.

Clin Cancer Res. 2008 Jun 1;14(11):3248-53. doi: 10.1158/1078-0432.CCR-07-4725.

PMID:
18519749
[PubMed - indexed for MEDLINE]
Free Article
14.

No association between SNP309 promoter polymorphism in the MDM2 and cervical cancer in a study from northeastern Brazil.

Meissner Rde V, Barbosa RN, Fernandes JV, Galvão TM, Galvão AF, Oliveira GH.

Cancer Detect Prev. 2007;31(5):371-4. Epub 2007 Nov 26.

PMID:
18023538
[PubMed - indexed for MEDLINE]
15.

Association of rheumatoid arthritis with Mdm2 SNP309 and genetic evidence for an allele-specific interaction between MDM2 and p53 P72R variants: a case control study.

Assmann G, Voswinkel J, Mueller M, Bittenbring J, Koenig J, Menzel A, Pfreundschuh M, Roemer K, Melchers I.

Clin Exp Rheumatol. 2009 Jul-Aug;27(4):615-9.

PMID:
19772793
[PubMed - indexed for MEDLINE]
16.

Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors.

Idbaih A, Boisselier B, Marie Y, Sanson M, El Hallani S, Crinière E, Fourtassi M, Paris S, Carpentier C, Rousseau A, Mokhtari K, Combadière C, Laigle-Donadey F, Hoang-Xuan K, Delattre JY.

Brain Res. 2008 Mar 10;1198:16-20. doi: 10.1016/j.brainres.2008.01.027. Epub 2008 Jan 18.

PMID:
18262501
[PubMed - indexed for MEDLINE]
17.

No association between MDM2 SNP309 promoter polymorphism and basal cell carcinoma of the skin.

Wilkening S, Hemminki K, Rudnai P, Gurzau E, Koppova K, Försti A, Kumar R.

Br J Dermatol. 2007 Aug;157(2):375-7. Epub 2007 Jun 6.

PMID:
17553029
[PubMed - indexed for MEDLINE]
18.

MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C.

Dharel N, Kato N, Muroyama R, Moriyama M, Shao RX, Kawabe T, Omata M.

Clin Cancer Res. 2006 Aug 15;12(16):4867-71.

PMID:
16914573
[PubMed - indexed for MEDLINE]
Free Article
19.

[Genetic polymorphism in MDM2 is associated with susceptibility to colorectal cancer in a Chinese population].

Liu JN, Zhang XM, Guo YL, Sun T, Lin DX, Wen T.

Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):335-8. Chinese.

PMID:
18953830
[PubMed - indexed for MEDLINE]
20.

Associations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non-small-cell lung cancer patients with wild-type p53 tumors.

Chien WP, Wong RH, Cheng YW, Chen CY, Lee H.

Ann Surg Oncol. 2010 Apr;17(4):1194-202. doi: 10.1245/s10434-009-0853-2. Epub 2009 Nov 26.

PMID:
19941079
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk